NCT04729205 2023-09-14
Assessment of Safety and Therapeutic Efficacy of Promitil in Combination With Folfox in Patients With GI Malignancies
Lipomedix Pharmaceuticals Inc.
Phase 1 Terminated
Lipomedix Pharmaceuticals Inc.
Hospital Universitari de Bellvitge
University of Saskatchewan
European Organisation for Research and Treatment of Cancer - EORTC